2591 — Guangzhou Innogen Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$1.50bn
- HK$472.79m
- CNY131.51m
Brief: Guangzhou Innogen Pharmaceutical Says Xu Wenjie Resigns As Executive Director
Brief: Guangzhou Innogen Pharmaceutical Group Co's Founder, Senior Management Undertakes Six-Month Lock-Up
Brief: Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase
Brief: GUANGZHOU INNOGEN PHARMACEUTICAL Posts HY LOSS Of RMB115.5 MLN
Brief: Guangzhou Innogen Pharmaceutical Obtains PIC/S GMP Certificates For Contract Manufacturing Sites
Guangzhou Innogen climbs on clinical trials approval on obesity drug
Brief: Guangzhou Innogen Pharmaceutical Says On 17 June, Receives Approval To Start Phase IB Trial
Brief: Guangzhou Innogen Pharmaceutical Posts FY Revenue Rmb131.5 Million
Brief: Guangzhou Innogen Pharmaceutical Expects RMB341.4 Million Loss For Year
Guangzhou Innogen jumps most in 10 weeks on Veterinary Drug Application
Brief: Guangzhou Innogen Pharmaceutical Says Veterinary Drug Application Accepted By MARA
Brief: Guangzhou Innogen Pharmaceutical, Unit On Dec 1 Subscribed Structured Deposit Product
Brief: Guangzhou Innogen Pharmaceutical & Unit Subscribes For Structured Deposit Product
Brief: Guangzhou Innogen Pharmaceutical Says Unit Subscribes To Structured Deposit For RMB105 Million
Brief: Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 Million